IN-LICENSED TECHNOLOGY - Skinvisible (Details) - Skinvisible Licensing agreement $ in Millions |
1 Months Ended |
|---|---|
|
Oct. 31, 2019
USD ($)
| |
| IN-LICENSED TECHNOLOGY | |
| License Fee | $ 1 |
| Percentage of revenues to be paid | 25.00% |
| Amount of payment to be made | $ 5 |
| X | ||||||||||
- Definition Represents the percentage of revenues to be paid under asset acquisition. No definition available.
|
| X | ||||||||||
- Definition Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of liability recognized from contingent consideration in asset acquisition. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|